Medicare, Reversing Itself, Will Pay More for an Expensive New Cancer Drug
Saturday, August 8, 2015 - 21:40
in Health & Medicine
The Obama administration has decided that Medicare will pay for one of the newest, most expensive cancer medications, Blincyto, which costs about $178,000 and treats an aggressive form of leukemia.